University of Colorado School of Medicine

We are developing a method for peptide sequencing that will increase throughput and sensitivity of protein detection by orders of magnitude.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Aurora, CO, USA
  • Currency USD
  • Employees 2

Company Summary

Team

  • Mantas Prekeris

    Monty is the lead engineer for the development of microfluidic platforms for data analysis and software development.

  • Kerri York

    Kerri is the technical lead for developing and optimizing peptide derivatization and cleavage schemes.

  • Jay Hesselberth
    Dr.

    I am the originator of the concepts underlying next-generation peptide sequencing and am intimately involved in the design and implementation of the technology.

  • Jay Hesselberth

Advisors

  • Patent filed with Swanson & Bratschun LLC
    Lawyer
    Unconfirmed

Previous Investors

  • Damon Runyon Cancer Research Foundation / Andy Rachleff
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free